InvestorsHub Logo
Followers 7
Posts 1361
Boards Moderated 0
Alias Born 12/23/2017

Re: Man6677 post# 15708

Wednesday, 05/16/2018 4:51:20 PM

Wednesday, May 16, 2018 4:51:20 PM

Post# of 70338
I continue to struggle with valuation - it seems most determining value are still leveraging dry cannabis sales as the core guide. But Aurora can make money on HEMP (product line there can grow exponentially), CBD (products there are endless), Greenhouse builds, Dry Cannabis, Medical (ever-growing customer base) and Rec sales (post approval), and they can sell all internationally, through various distribution channels, and they have a white label version of Namaste's NamasteMD.com portal to grow customer base. They have a huge potential for supplying their own customers and, if needed, selling to other businesses their various products, both formed in their medical area as well as branded retail cannabis. They also make money on investments in other companies, which they later can sell their stake in. So they have options for revenue in multiple arenas in a nascent industry. I can't anticipate what that market will be, but billions in a year seems highly likely just on dry cannabis alone. Oils, CBD, HEMP, Greenhouses, investments, just adds to the "pot". I don't like seeing share structure increase, but I think everyone is whistling in the wind as to what that really means in terms of value for a stock like ACBFF. Is less shares better, sure. The impact of current dilution on value - far less sure in the long term, impact is all short term and based on guesses. Guessing makes for uncertainty, uncertainty leads to lower PPS.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACB News